サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405757

創薬インフォマティクスの市場規模、シェア、動向分析レポート：ワークフロー別、サービス別、地域別、セグメント予測、2023年～2030年

Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Workflow (Discovery Informatics, Biocontent Management), By Services (Sequence Analysis Platform), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
創薬インフォマティクスの市場規模、シェア、動向分析レポート：ワークフロー別、サービス別、地域別、セグメント予測、2023年～2030年
出版日: 2023年12月01日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

創薬インフォマティクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の創薬インフォマティクス市場規模は、2023年から2030年にかけて11.2%のCAGRを記録し、2030年までに68億6,000万米ドルに達する見込みです。

迅速な薬剤設計・合成、疾患進展の効率的な追跡、データの完全性管理など、いくつかの利点があるため、市場情報を得るために創薬ソフトウェアを使用することが、近年研究者の間で大幅に増加し、業界の成長を牽引しています。

新規分子に対する需要の高まりは、標的高分子の相互作用を通じて合理的な薬剤分子を同定することで、創薬プロセス全体のスピードアップを目指すインフォマティクス・ソリューションの採用を後押ししています。同市場で事業を展開する企業は、創薬プラットフォームの拡大のために資金援助を受けており、市場の成長をさらに補完しています。例えば、2020年9月、アルディジェンは国立研究開発センターと契約を結び、新規技術開発のための資金提供を受けることになった。

この技術は、免疫腫瘍学のためのT細胞受容体に基づく治療法の開発に革命を起こすことを目的としていました。アルディジェンはこれまでに、ネオアンチゲン予測プラットフォームArdImmune Vaxを開発しており、養子細胞療法やがんワクチンの標的として最適なネオアンチゲンを同定するために、すぐに使える人工知能（AI）とバイオインフォマティクス・ソリューションを展開しています。加えて、ケミカル・インフォマティクス・ソリューションは、特に最近のCOVID-19パンデミックに関連するニーズに対応する上で、この1年で大きな支持を得た。

例えば、2021年1月に行われた調査では、SARS-CoV-2 Mpro阻害剤の探索を加速するために、SARS-CoVメインプロテアーゼ（Mpro）阻害剤の過去の活性データのデータ解析による化学デジタルソリューションの応用が紹介されました。さらに、QSARモデルは、迅速なCOVID-19創薬のための分子のデータマイニングに役立ちました。したがって、COVID-19の医薬品開発を促進する必要性が、今後数年間の業界拡大を促進すると予想されます。

創薬インフォマティクス市場レポート・ハイライト

  • 医薬品開発ワークフロー分野は、臨床開発段階にある医薬品候補の数の増加により、2022年から2030年にかけて10.9%という最も高い複合年間成長率（CAGR）を示すと予測されます。
  • 創薬インフォマティクス分野は、2022年に約60%の最大収益シェアを占め、精密医薬品の開発に大きな焦点が当てられています。精密医療は、個人の遺伝的・分子的プロファイルに合わせた個別化医療の提供を中心に展開されています。
  • 米国が主導する北米は、主要市場プレイヤーの存在と確立された研究開発インフラにより、2022年の世界市場をリードしました。
  • 主要市場参入企業は、市場競争を維持するために戦略的買収に注力しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 創薬インフォマティクス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 創薬インフォマティクス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 創薬インフォマティクス：ワークフローの推定・動向分析

  • 創薬インフォマティクス市場：重要なポイント
  • 創薬インフォマティクス市場：動向と市場シェア分析、2022年および2030年
  • ディスカバリーインフォマティクス
  • 生体含有量の管理

第5章 創薬インフォマティクス：サービスの推定・動向分析

  • 創薬インフォマティクス市場：重要なポイント
  • 創薬インフォマティクス市場：動向と市場シェア分析、2022年および2030年
  • 配列解析プラットフォーム
  • 分子モデリング
  • ドッキング
  • 臨床試験データ管理
  • その他

第6章 創薬情報市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別の創薬情報市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Certara
    • Boehringer Ingelheim International GmbH
    • Infosys Ltd.
    • Charles River Laboratories
    • Collaborative Drug Discovery, Inc.
    • Eurofins DiscoverX Products
    • Jubilant Biosys
    • Selvita
    • Novo Informatics Pvt. Ltd.
    • ChemAxon Ltd.
    • Albany Molecular Research Inc.
    • Oracle
    • Accenture
    • Agilent Technologies, Inc.
    • Illumina, Inc.
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 3 North America drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 4 North America drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 U.S. drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 7 U.S. drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 8 Canada drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 9 Canada drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 10 Canada drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 11 Europe drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 12 Europe drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 13 Europe drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 14 Germany drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 15 Germany drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 16 Germany drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 17 UK drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 UK drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 19 UK drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 20 France drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 21 France drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 22 France drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 23 Italy drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 24 Italy drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 25 Italy drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 26 Spain drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Spain drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 28 Spain drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 29 Sweden drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 30 Sweden drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 31 Sweden drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 32 Norway drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 33 Norway drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 34 Norway drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 35 Denmark drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 36 Denmark drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 37 Denmark drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 41 China drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 42 China drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 43 China drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 45 Japan drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 46 Japan drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 47 India drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 48 India drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 49 India drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 50 Thailand drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Thailand drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 52 Thailand drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 53 South Korea drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 54 South Korea drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 55 South Korea drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 56 Latin America drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 57 Latin America drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 58 Latin America drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 59 Brazil drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 60 Brazil drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 61 Brazil drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 62 Mexico drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 63 Mexico drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 64 Mexico drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 65 Argentina drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 66 Argentina drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 67 Argentina drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 68 Middle East and Africa drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Middle East and Africa drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 70 Middle East and Africa drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 71 South Africa drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 South Africa drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 73 South Africa drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 74 Saudi Arabia drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 77 UAE drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 78 UAE drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 79 UAE drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 80 Kuwait drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 81 Kuwait drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 82 Kuwait drug discovery informatics market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig.1 Market research process
  • Fig.2 Data triangulation techniques
  • Fig.3 Primary research pattern
  • Fig.4 Market research approaches
  • Fig.5 Value-chain-based sizing & forecasting
  • Fig.6 QFD modeling for market share assessment
  • Fig.7 Market formulation & validation
  • Fig.8 Drug Discovery Informatics s: market outlook
  • Fig.9 Drug Discovery Informatics s competitive insights
  • Fig.10 Parent market outlook
  • Fig.11 Related/ancillary market outlook
  • Fig.12 Penetration and growth prospect mapping
  • Fig.13 Industry value chain analysis
  • Fig.14 Drug Discovery Informatics market driver impact
  • Fig.15 Drug Discovery Informatics market restraint impact
  • Fig.16 Drug Discovery Informatics market strategic initiatives analysis
  • Fig.17 Drug Discovery Informatics market: Workflow movement analysis
  • Fig.18 Drug Discovery Informatics market: Workflow outlook and key takeaways
  • Fig.19 Discovery informatics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.20 Biocontent management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.22 Drug Discovery Informatics market: Services movement analysis
  • Fig.23 Drug Discovery Informatics market: Services outlook and key takeaways
  • Fig.24 Sequence analysis platforms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.25 Molecular modelling market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.26 Docking market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.27 Clinical trial data management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.29 Global Drug Discovery Informatics market: regional movement analysis
  • Fig.30 Global Drug Discovery Informatics market: regional outlook and key takeaways
  • Fig.31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.37 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.40 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.41 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.44 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.45 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.46 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.48 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.49 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.52 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.53 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.57 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-749-0

Drug Discovery Informatics Market Growth & Trends:

The global drug discovery informatics market size is expected to reach USD 6.86 billion by 2030, registering a CAGR of 11.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.

The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macromolecule interaction. Companies operating in the market are receiving funding for expanding their drug discovery platforms, further supplementing the market growth. For instance, in September 2020, Ardigen signed an agreement with the National Centre for Research and Development to access its funding for developing novel technology.

This technology was aimed at revolutionizing the development of T-cell receptors-based therapies for immuno-oncology. Ardigen has previously developed a neoantigen prediction platform namely, ArdImmune Vax, which deploys ready-to-use Artificial Intelligence (AI) and bioinformatics solutions for the identification of optimal sets of neoantigens as targets for adoptive cell therapies and cancer vaccines. In addition, chemical informatics solutions have gained considerable traction in the past year, particularly in addressing the needs associated with the recent COVID-19 pandemic.

For instance, a research study performed in January 2021 showcased the application of chemical digital solutions in accelerating the search of SARS-CoV-2 Mpro inhibitors by data analysis of previous activity data of SARS-CoV main protease (Mpro) inhibitors. In addition, the QSAR models helped in the data mining of molecules for rapid COVID-19 drug discovery. Hence, the need to facilitate drug development for COVID-19 is expected to propel the industry expansion over the coming years.

Drug Discovery Informatics Market Report Highlights:

  • The drug development workflow segment is projected to exhibit the highest compound annual growth rate (CAGR) of 10.9% from 2022 to 2030 owing to a rise in the number of drug candidates in the clinical development phase
  • The discovery informatics segment accounted for the largest revenue share of around 60% in 2022, with a major focus on developing precision medicines. Precision medicine revolves around providing personalized medical care tailored to an individual's genetic and molecular profile.
  • Led by the U.S., North America led the global market in 2022 due to the presence of key market players and established R&D infrastructure in the country
  • Key industry participants focus on strategic acquisitions to sustain the market competition

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Workflow
    • 1.1.2. Services
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Workflow outlook
    • 2.2.2. Services outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Discovery Informatics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Drug Discovery Informatics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Drug Discovery Informatics: Workflow Estimates & Trend Analysis

  • 4.1. Drug Discovery Informatics Market: Key Takeaways
  • 4.2. Drug Discovery Informatics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Discovery Informatics
    • 4.3.1. Discovery Informatics market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Biocontent Management
    • 4.4.1. Biocontent Management market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Drug Discovery Informatics: Services Estimates & Trend Analysis

  • 5.1. Drug Discovery Informatics Market: Key Takeaways
  • 5.2. Drug Discovery Informatics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Sequence Analysis Platform
    • 5.3.1. Sequence analysis platform market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.4. Molecular Modelling
    • 5.4.1. Molecular Modelling market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Docking
    • 5.5.1. Docking market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Clinical Trial Data Management
    • 5.6.1. Clinical Trial Data Management market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Drug Discovery Informatics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Drug Discovery Informatics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Certara
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Boehringer Ingelheim International GmbH
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Infosys Ltd.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Charles River Laboratories
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Collaborative Drug Discovery, Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Eurofins DiscoverX Products
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Jubilant Biosys
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Selvita
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Novo Informatics Pvt. Ltd.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. ChemAxon Ltd.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Albany Molecular Research Inc.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Oracle
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Accenture
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Agilent Technologies, Inc.
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Illumina, Inc.
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives